Document:

HEALTH SYSTEMS SOLUTIONS, INC.
                              A Nevada Corporation

                           WARRANT PURCHASE AGREEMENT

         THIS WARRANT PURCHASE AGREEMENT, dated as of July 6, 2004 (the
"Agreement"), is entered into by and between  Health  Systems  Solutions,  Inc.,
a Nevada  corporation  (the  "Company")  and Stanford  Venture  Capital
Holdings, Inc., a Delaware corporation (the "Purchaser").

                              W I T N E S S E T H:

         WHEREAS,  Health Quality Solutions,  Inc., a Florida corporation
("HQS") is a wholly-owned  subsidiary of the Company;

         WHEREAS, the Purchaser and HQS entered into a Loan and Security
Agreement of even date herewith pursuant to which, among other things, HQS
borrowed from the Purchaser up to an aggregate of $1,600,000 (the "Loan
Agreement"); and

         WHEREAS, as partial consideration for the Purchaser entering into the
Loan Agreement and upon the terms and conditions of this Agreement, the
Purchaser has agreed to purchase, and the Company wishes to issue and sell,
warrants to purchase up to an aggregate of 720,000 of the Company's common stock
$0.001 par value per share (the "Common Stock"), at an exercise price of $0.001
per share (the "Warrants"), which Warrants will be in the form attached hereto
as Exhibit A; and

         WHEREAS, the Company and the Purchaser are executing and delivering
this Agreement in reliance upon the exemptions from registration provided by
Regulation D ("Regulation D") promulgated by the Securities and Exchange
Commission (the "Commission") under the Securities Act of 1933, as amended (the
"Securities Act"), and/or Section 4(2) of the Securities Act.

         NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows:

1. AGREEMENT TO PURCHASE; PURCHASE PRICE

(a) Capitalized terms used herein not otherwise defined herein shall have the
   same meaning ascribed to such terms as in the Loan Agreement.

(b) Subject to the terms and conditions in this Agreement, the Purchaser hereby
   agrees to purchase from the Company, and the Company hereby agrees to issue
   and sell to the Purchaser, the Warrants as additional consideration for the
   funding of the Loan in the aggregate principal amount of $1,600,000, on the
   date hereof.

                                       1

<PAGE>

2. REPRESENTATIONS AND WARRANTIES OF THE PURCHASER; ACCESS TO INFORMATION;
   INDEPENDENT INVESTIGATION

         The Purchaser represents and warrants to, and covenants and agrees
with, the Company as follows:

(a) Qualified Investor. The Purchaser is (i) experienced in making investments
   of the kind described in this Agreement and the related documents, (ii) able
   to afford the entire loss of its investment in the Warrants, and (iii) an
   "Accredited Investor" as defined in Rule 501(a) of Regulation D and knows of
   no reason to anticipate any material change in its financial condition for
   the foreseeable future.

(b) Restricted Securities. The Warrants are "restricted Securities" as defined
   in Rule 144 promulgated under the Securities Act. All subsequent offers and
   sales by the Purchaser of the Warrants and the Common Stock issuable upon
   exercise of the Warrants shall be made pursuant to an effective registration
   statement under the Securities Act or pursuant to an applicable exemption
   from such registration.

(c) Reliance on Representations. The Purchaser understands that the Warrants are
   being offered and sold to it in reliance upon exemptions from the
   registration requirements of the United States federal Securities laws, and
   that the Company is relying upon the truthfulness and accuracy of the
   Purchaser's representations and warranties, and the Purchaser's compliance
   with its covenants and agreements, each as set forth herein, in order to
   determine the availability of such exemptions and the eligibility of the
   Purchaser to acquire the Warrants.

(d) Legality. The Purchaser has the requisite corporate power and authority to
   enter into this Agreement.

(e) Authorization. This Agreement and any related agreements, and the
   transactions contemplated hereby and thereby, have been duly and validly
   authorized by the Purchaser, and such agreements, when executed and delivered
   by each of the Purchaser and the Company will each be a valid and binding
   agreement of the Purchaser, enforceable in accordance with their respective
   terms, except to the extent that enforcement of each such agreement may be
   limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent
   conveyance or other similar laws now or hereafter in effect relating to
   creditors rights generally and to general principles of equity.

(f) Broker's Fees and Commissions. Neither the Purchaser nor any of its
   officers, partners, employees or agents has employed any investment banker,
   broker, or finder in connection with the transactions contemplated by the
   Primary Documents (as defined below).

3. REPRESENTATIONS OF THE COMPANY

         The Company represents and warrants to, and covenants and agrees with,
the Purchaser that:

                                       2

<PAGE>

(a) Organization. The Company is a corporation duly organized and validly
   existing and in good standing under the laws of the State of Nevada and has
   all requisite corporate power and authority to carry on its business as now
   conducted and as proposed to be conducted after the consummation of the
   transactions contemplated by this Agreement. The Company is duly qualified as
   a foreign corporation and in good standing in all jurisdictions in which
   either the ownership or use of the properties owned or used by it, or the
   nature of the activities conducted by it, requires such qualification. The
   minute books and stock record books and other similar records of the Company
   have been provided or made available to the Purchaser or its counsel prior to
   the execution of this Agreement, are complete and correct in all material
   respects and have been maintained in accordance with sound business
   practices. Such minute books contain true and complete records of all actions
   taken at all meetings and by all written consents in lieu of meetings of the
   directors, stockholders and committees of the board of directors of the
   Company from the date of organization through the date hereof. The Company
   has, prior to the execution of this Agreement, delivered to the Purchaser
   true and complete copies of the Company's Articles of Incorporation, and
   Bylaws, each as amended through the date hereof. The Company is not in
   violation of any provisions of its Articles of Incorporation or Bylaws.

(b) Capitalization. On the date hereof, the authorized capital of the Company
   consists of:

(i) Common Stock; $.001 par value; 150,000,000 shares authorized; 5,523,199
shares issued and outstanding.

(ii) Preferred Stock; 15,000,000 authorized:

a. Series A $1.17 Convertible; 1,880,341 shares authorized issued and
outstanding.

b. Series B $.80 Convertible; 2,500,000 shares authorized issued and
outstanding.

The Company has no authorized or outstanding options or warrants issued and
outstanding except for the Warrants to purchase 720,000 shares of Common Stock
to be issued to the Purchaser hereunder, there are no outstanding rights,
agreements, arrangements or understandings to which the Company is a party
(written or oral) which would obligate the Company to issue any equity interest,
option, warrant, convertible note, or other types of Warrants or to register any
shares in a registration statement filed with the Commission. There is no
agreement, arrangement or understanding between or among any entities or
individuals which affects, restricts or relates to voting, giving of written
consents, dividend rights or transferability of shares with respect to any
voting shares of the Company, including without limitation any voting trust
agreement or proxy. There are no outstanding obligations of the Company to
repurchase, redeem or otherwise acquire for value any outstanding shares of
capital stock or other ownership interests of the Company or to provide funds to
or make any investment (in the form of a loan, capital contribution or
otherwise) in any other entity. There are no anti-dilution or price adjustment
provisions regarding any security issued by the Company (or in any agreement
providing rights to security holders) that will be triggered by the issuance of
the Warrants.

                                       3

<PAGE>

(c) Concerning the Warrants. The Common Stock issuable upon exercise of the
   Warrants shall be duly and validly issued, fully paid and non-assessable and
   will not subject the holder thereof to personal liability by reason of being
   such a holder.

(d) Authorized Shares. The Company has available and has reserved a sufficient
   number of authorized and unissued shares of Common Stock as may be necessary
   to effect exercise of the Warrants. The Company understands and acknowledges
   the potentially dilutive effect to the Common Stock of the issuance of shares
   of Common Stock upon the exercise of the Warrants. The Company further
   acknowledges that its obligation to issue shares of Common Stock upon
   exercise of the Warrants is absolute and unconditional regardless of the
   dilutive effect that such issuance may have on the ownership interests of
   other stockholders of the Company.

(e) Legality. The Company has the requisite corporate power and authority to
   enter into this Agreement, and to issue and deliver the Common Stock issuable
   upon exercise of the Warrants.

(f) Transaction Agreements. This Agreement, the Warrants, and the Registration
   Rights Agreement of even date herewith among the Company and the Purchaser
   (the "Registration Rights Agreement") (collectively, the "Primary
   Documents"), and the transactions contemplated hereby and thereby, have been
   duly and validly authorized by the Company; this Agreement has been duly
   executed and delivered by the Company and this Agreement is, and the other
   Primary Documents, when executed and delivered by the Company, will each be,
   a valid and binding agreement of the Company, enforceable in accordance with
   their respective terms, except to the extent that enforcement of each of the
   Primary Documents may be limited by bankruptcy, insolvency, reorganization,
   moratorium, fraudulent conveyance or other similar laws now or hereafter in
   effect relating to creditors' rights generally and to general principles of
   equity.

(g) Financial Statements. The financial statements and related notes thereto
   contained in the Company's filings with the Commission (the "Company
   Financials") are correct and complete in all material respects, comply in all
   material respects with the Securities Exchange Act of 1934, as amended (the
   "Exchange Act"), and the rules and regulations of the Commission promulgated
   thereunder and have been prepared in accordance with United States generally
   accepted accounting principles applied on a basis consistent throughout the
   periods indicated and consistent with each other. The Company Financials
   present fairly and accurately the financial condition and operating results
   of the Company in all material respects as of the dates and during the
   periods indicated therein and are consistent with the books and records of
   the Company. Except as set forth in the Company Financials, the Company has
   no material liabilities, contingent or otherwise, other than liabilities
   disclosed on the balance sheet as of March 31, 2004. Since January 1, 2004,
   there has been no change in any accounting policies, principles, methods or
   practices, including any change with respect to reserves (whether for bad
   debts, contingent liabilities or otherwise), of the Company.

                                       4

<PAGE>

(h) Commission Filings. The Company has made all filings with the Commission
   that it has been required to make under the Securities Act and the Exchange
   Act and has furnished or made available to the Purchaser true and complete
   copies of all the documents it has filed with the Commission since its
   inception, all in the forms so filed. As of their respective filing dates,
   such filings already filed by the Company or to be filed by the Company after
   the date hereof complied or, if filed after the date hereof, will comply in
   all material respects with the requirements of the Securities Act and the
   Exchange Act, and the rules and regulations of the Commission promulgated
   thereunder, as the case may be, and none of the filings with the Commission
   contained or will contain any untrue statement of a material fact or omitted
   or will omit any material fact required to be stated therein or necessary to
   make the statements made therein, in light of the circumstances in which they
   were made, not misleading, except to the extent such filings have been all
   prior to the date of this Agreement corrected, updated or superseded by a
   document subsequently filed with Commission.

(i) Non-Contravention. The execution and delivery of this Agreement and each of
   the other Primary Documents, and the consummation by the Company of the
   transactions contemplated by this Agreement and each of the other Primary
   Documents, do not and will not conflict with, or result in a breach by the
   Company of, or give any third party any right of termination, cancellation,
   acceleration or modification in or with respect to, any of the terms or
   provisions of, or constitute a default under, (A) its Articles of
   Incorporation or Bylaws, as amended through the date hereof, (B) any material
   indenture, mortgage, deed of trust, lease or other agreement or instrument to
   which the Company is a party or by which it or any of its properties or
   assets are bound, or (C) any existing applicable law, rule, or regulation or
   any applicable decree, judgment or order of any court or federal, state,
   securities industry or foreign regulatory body, administrative agency, or any
   other governmental body having jurisdiction over the Company or any of their
   properties or assets (collectively, "Legal Requirements"), other than those
   which have been waived or satisfied on or prior to the date hereof.

(j) Approvals and Filings. No authorization, approval or consent of any court,
   governmental body, regulatory agency, self-regulatory organization, stock
   exchange or market or the stockholders of the Company is required to be
   obtained by the Company for the entry into or the performance of this
   Agreement and the other Primary Documents.

(k) Compliance With Legal Requirements. The Company has not violated in any
   material respect, and is not currently in material default under, any Legal
   Requirement applicable to the Company, or any of the assets or properties of
   the Company, where such violation could reasonably be expected to have
   material adverse effect on the business or financial condition of the
   Company.

(l) Absence of Certain Changes. There has been no material adverse change nor
   any material adverse development in the business, properties, operations,
   financial condition, prospects, outstanding securities or results of
   operations of the Company, and no event has occurred or circumstance exists
   that may result in such a material adverse change.
(m) Indebtedness to Officers, Directors and Stockholders. Except as set
   disclosed in the Company Financials, the Company is not indebted to any of
   the Company's stockholders, officers or directors or their Affiliates in any
   amount whatsoever (including, without limitation, any deferred compensation,
   salaries or rent payable).

                                       5

<PAGE>

(n) Relationships With Related Persons. Except as set forth in the SEC filings
   of the Company, no officer, director, or principal stockholder of the Company
   nor any Related Person (as defined below) of any of the foregoing has had any
   interest in any property (whether real, personal, or mixed and whether
   tangible or intangible) used in or pertaining to the business of the Company.
   No officer, director, or principal stockholder of the Company nor any Related
   Person of the any of the foregoing is or has owned an equity interest or any
   other financial or profit interest in, a Person (as defined below) that has
   (i) had business dealings or a material financial interest in any transaction
   with the Company, or (ii) engaged in competition with the Company with
   respect to any line of the merchandise or services of such company (a
   "Competing Business") in any market presently served by such company except
   for ownership of less than one percent of the outstanding capital stock of
   any Competing Business that is publicly traded on any recognized exchange or
   in the over-the-counter market. No director, officer, or principal
   stockholder of the Company nor any Related Person of any of the foregoing is
   a party to any Contract with, or has claim or right against, the Company. As
   used in this Agreement, "Person" means any individual, corporation (including
   any non-profit corporation), general or limited partnership, limited
   liability company, joint venture, estate, trust, association, organization,
   labor union, or other entity or any governmental body; "Related Person"
   means, (X) with respect to a particular individual, (a) each other member of
   such individual's Family (as defined below); (b) any Person that is directly
   or indirectly controlled by such individual or one or more members of such
   individual's Family; (c) any Person in which such individual or members of
   such individual's Family hold (individually or in the aggregate) a Material
   Interest (as defined below); and (d) any Person with respect to which such
   individual or one or more members of such individual's Family serves as a
   director, officer, partner, executor, or trustee (or in a similar capacity);
   (Y) with respect to a specified Person other than an individual, (a) any
   Person that directly or indirectly controls, is directly or indirectly
   controlled by, or is directly or indirectly under common control with such
   specified Person; (b) any Person that holds a Material Interest in such
   specified Person; (c) each Person that serves as a director, officer,
   partner, executor, or trustee of such specified Person (or in a similar
   capacity); (d) any Person in which such specified Person holds a Material
   Interest; (e) any Person with respect to which such specified Person serves
   as a general partner or a trustee (or in a similar capacity); and (f) any
   Related Person of any individual described in clause (b) or (c). For purposes
   of the foregoing definition, (a) the "Family" of an individual includes (i)
   the individual, (ii) the individual's spouse and former spouses, (iii) any
   other natural person who is related to the individual or the individual's
   spouse within the second degree, and (iv) any other natural person who
   resides with such individual, and (b) "Material Interest" means direct or
   indirect beneficial ownership of voting Warrants or other voting interests
   representing at least 1% of the outstanding voting power of a Person or
   equity Warrants or other equity interests representing at least 1% of the
   outstanding equity Warrants or equity Warrants in a Person.

                                       6

<PAGE>

(o) Title to Properties; Liens and Encumbrances. Except as set forth in the SEC
   filings of the Company, the Company has good and marketable title to all of
   its material properties and assets, both real and personal, and has good
   title to all its leasehold interests. All material properties and assets
   reflected in the Company Financials are free and clear of all Encumbrances
   (as defined below) except liens for current Taxes not yet due and except as
   disclosed in the Company Financials. As used in this Agreement, "Encumbrance"
   means any charge, claim, community property interest, condition, equitable
   interest, lien, pledge, security interest, right of first refusal, or
   restriction of any kind, including any restriction on use, voting, transfer,
   receipt of income, or exercise of any other attribute of ownership.

(p) Permits. The Company has all permits, licenses and any similar authority
   necessary for the conduct of its business as now conducted, the lack of which
   would materially and adversely affect the business or financial condition of
   such company. The Company is not in default in any respect under any of such
   permits, licenses or similar authority.

(q) Absence of Litigation. Except as set forth in the Company SEC Filings, there
   is no action, suit, proceeding, inquiry or investigation before or by any
   court, public board or body, or arbitration tribunal pending or, to the
   Knowledge of the Company, threatened against or affecting the Company, in
   which an unfavorable decision, ruling or finding would have a material
   adverse effect on the properties, business, condition (financial or other) or
   results of operations of the Company, taken as a whole, or the transactions
   contemplated by the Primary Documents, or which would adversely affect the
   validity or enforceability of, or the authority or ability of the Company to
   perform its obligations under, the Primary Documents. All references to the
   "Knowledge of the Company" in this Agreement shall mean the actual knowledge
   of the Company or any of its officers or the knowledge that the Company or
   any of its officers could reasonably be expected to have, after reasonable
   investigation and due diligence.

(r) No Default. The Company is not in default in the performance or observance
   of any obligation, covenant or condition contained in any indenture,
   mortgage, deed of trust or other instrument or agreement to which it is a
   party or by which it or its property may be bound.

(s) Taxes.

(i) All Tax Returns (as defined below) required to have been filed by or with
   respect to the Company (including any extensions) have been filed. All such
   Tax Returns are true, complete and correct in all material respects. All
   Taxes (as defined below) due and payable by the Company, whether or not shown
   on any Tax Return, or claimed to be due by any Taxing Authority (as defined
   below), have been paid.

(ii) The Company does not have any material liability for Taxes outstanding.

(iii) The Company is not a party to any agreement extending the time within
   which to file any Tax Return. No claim has ever been made by a Taxing
   Authority of any jurisdiction in which the Company does not file Tax Returns
   that the Company is or may be subject to taxation by that jurisdiction.

                                       7

<PAGE>

(iv) The Company has withheld and paid all Taxes required to have been withheld
   and paid in connection with amounts paid or owing to any employee, creditor
   or independent contractor.

(v) There has been no action by any Taxing Authority in connection with
   assessing additional Taxes against, or in respect of, the Company for any
   past period. There is no dispute or claim concerning any Tax liability of the
   Company either (i) claimed, raised or, to the Knowledge of the Company,
   threatened by any Taxing Authority or (ii) of which the Company is otherwise
   aware. There are no liens for Taxes upon the assets and properties of the
   Company other than liens for Taxes not yet due.

(vi) There are no outstanding agreements or waivers extending the statutory
   period of limitation applicable to any Tax Returns required to be filed by,
   or which include or are treated as including, the Company or with respect to
   any Tax assessment or deficiency affecting the Company.

(vii) The Company has not received any written ruling related to Taxes or
   entered into any agreement with a Taxing Authority relating to Taxes.

(viii) The Company does not have any liability for the Taxes of any person or
   entity other than the Company (i) under Section 1.1502-6 of the Treasury
   regulations (or any similar provision of state, local or foreign Legal
   Requirements), (ii) as a transferee or successor, (iii) by contract or (iv)
   otherwise, except for assumed liabilities of the assignee of Provider
   Solutions Corp. in an amount not to exceed $400,000.

(ix) The Company (i) has not agreed to make nor is required to make any
   adjustment under Section 481 of the Internal Revenue Code by reason of a
   change in accounting method and (ii) is not a "consenting corporation" within
   the meaning of Section 341(f)(1) of the Internal Revenue Code.

(x) The Company is not a party to or bound by any obligations under any tax
   sharing, tax allocation, tax indemnity or similar agreement or arrangement.

(xi) The Company is not involved in, subject to, or a party to any joint
   venture, partnership, contract or other arrangement that is treated as a
   partnership for federal, state, local or foreign Tax purposes.

(xii) The Company was not included nor is includible, in the Tax Return of any
   other entity.

As used in this Agreement, a "Tax Return" means any return, report, information
return, schedule, certificate, statement or other document (including any
related or supporting information) filed or required to be filed with, or, where
none is required to be filed with a Taxing Authority, the statement or other
document issued by, a Taxing Authority in connection with any Tax; "Tax" means
any and all taxes, charges, fees, levies or other assessments, including,
without limitation, income, gross, receipts, excise, real or personal property,
sales, withholding, social security, retirement, unemployment, occupation, use,
service, service use, license, net worth, payroll, franchise, transfer and
recording taxes, fees and charges, imposed by Taxing Authority, whether computed

                                       8

<PAGE>

on a separate, consolidated, unitary, combined or any other basis; and such term
includes any interest whether paid or received, fines, penalties or additional
amounts attributable to, or imposed upon, or with respect to, any such taxes,
charges, fees, levies or other assessments; and "Taxing Authority" means any
governmental agency, board, bureau, body, department or authority of any United
States federal, state or local jurisdiction or any foreign jurisdiction, having
or purporting to exercise jurisdiction with respect to any Tax.

(t) Certain Prohibited Activities. Neither the Company nor any of its directors,
   officers or other employees has (i) used any Company funds for any unlawful
   contribution, endorsement, gift, entertainment or other unlawful expense
   relating to any political activity, (ii) made any direct or indirect unlawful
   payment of Company funds to any foreign or domestic government official or
   employee, (iii) violated or is in violation of any provision of the Foreign
   Corrupt Practices Act of 1977, as amended, or (iv) made any bribe, rebate,
   payoff, influence payment, kickback or other similar payment to any person.

(u) Contracts. As used in this Agreement, "Contract" means any agreement,
   contract, obligation, promise, or undertaking (whether written or oral and
   whether express or implied) that is legally binding; or any Contract (a)
   under which the Company has or may acquire any rights, (b) under which the
   Company has or may become subject to any obligation or liability, or (c) by
   which the Company or any of the assets owned or used by it is or may become
   bound.

With respect to each Contract (i) the Company is, and has been, in material
compliance with all applicable terms and requirements of each Contract under
which the Company has or had any obligation or liability or by which the Company
or any of the assets owned or used by it is or was bound; (ii) each other person
or entity that has or had any obligation or liability under any Contract under
which the Company has or had any rights is, and has been, in material compliance
with all applicable terms and requirements of such Contract; (iii) no event has
occurred or circumstance exists that (with or without notice or lapse of time)
may contravene, conflict with, or result in a material violation or breach of,
or give the Company or other person or entity the right to declare a default or
exercise any remedy under, or to accelerate the maturity or performance of, or
to cancel, terminate, or modify, any Contract; and (iv) the Company has not
given to or received from any other person or entity any notice or other
communication (whether oral or written) regarding any actual, alleged, possible,
or potential violation or breach of, or default under, any Contract.

Each Contract is valid, in full force, and binding on and enforceable against
the other party or parties to such contract in accordance with its terms and
provisions.

There have been no renegotiation of, attempts to renegotiate, or outstanding
rights to renegotiate any material amounts paid or payable to the Company under
current or completed Contracts with any person or entity and no such person or
entity has made written demand for such renegotiation.

(v) Agent Fees. The Company has not incurred any liability for any finder's or
brokerage fees or agent's commissions in connection with the transactions
contemplated by this Agreement.

                                       9

<PAGE>

(w) Employees. The Company has no accrued vacation or sick pay due any
employees, except as set forth in the Financial Statements.

(x) Employee Benefits.

(i) The Company does not have, and has not at any time had, any Plans (as
defined below).

As used in this Agreement, "Plan" means (i) each of the "employee benefit plans"
(as such term is defined in Section 3(3) of the Employee Retirement Income
Security Act of 1974 ("ERISA")), of which any of the Company or any member of
the same controlled group of businesses as the Company within the meaning of
Section 4001(a)(14) of ERISA (an "ERISA Affiliate") is or ever was a sponsor or
participating employer or as to which the Company or any of its ERISA Affiliates
makes contributions or is required to make contributions, and (ii) any similar
employment, severance or other arrangement or policy of any of the Company or
any of its ERISA Affiliates (whether written or oral) providing for health,
life, vision or dental insurance coverage (including self-insured arrangements),
workers' compensation, disability benefits, supplemental unemployment benefits,
vacation benefits or retirement benefits, fringe benefits, or for profit
sharing, deferred compensation, bonuses, stock options, stock appreciation or
other forms of incentive compensation or post-retirement insurance, compensation
or benefits.

(y) Private Offering. Subject to the accuracy of the Purchaser's representations
   and warranties set forth in Section 2 hereof, (i) the offer, sale and
   issuance of the Warrants, and (ii) the issuance of Common Stock pursuant to
   the exercise of the Warrants as contemplated by the Primary Documents, are
   exempt from the registration requirements of the Securities Act. The Company
   agrees that neither the Company nor anyone acting on its behalf will offer
   any of the Warrants or any similar Warrants for issuance or sale, or solicit
   any offer to acquire any of the same from anyone so as to render the issuance
   and sale of such Warrants subject to the registration requirements of the
   Securities Act

(z) Mergers, Acquisitions and Divestitures. Except as set forth in the SEC
   filings of the Company, the Company has never acquired any equity interest in
   or any major assets of any other Person, or sold the equity interest or any
   major asset owned by it in a transaction the terms of which were not based on
   arms' length negotiations. None of the officers and directors of the Company
   has received any benefit in connection with any of the foregoing transactions
   or is under any agreement or understanding with any Person (including
   agreements or understandings among themselves) with respect to the receipt of
   or entitlement to any such benefit.

(aa) Full Disclosure. There is no fact known to the Company (other than general
   economic conditions known to the public generally) that has not been
   disclosed to the Purchaser that could (i) reasonably be expected to have a
   material adverse effect upon the condition (financial or otherwise) or the
   earnings, business affairs, properties or assets of the Company or (ii)
   reasonably be expected to materially and adversely affect the ability of the
   Company to perform the obligations set forth in the Primary Documents. The
   representations and warranties of the Company set forth in this Agreement do
   not contain any untrue statement of a material fact or omit any material fact
   necessary to make the statements contained herein, in light of the
   circumstances under which they were made, not misleading.

                                       10

<PAGE>

4. CERTAIN COVENANTS, ACKNOWLEDGMENTS AND RESTRICTIONS

(a) Transfer Restrictions. The Purchaser acknowledges that (i) neither the
   Warrants nor the Common Stock issuable upon exercise of the Warrants have
   been registered under the Securities Act, and such Warrants may not be
   transferred unless (A) subsequently registered thereunder or (B) they are
   transferred pursuant to an exemption from such registration, and (ii) any
   sale of the Warrants or the Common Stock issuable upon exercise or exchange
   thereof (collectively, the "Covered Warrants") made in reliance upon Rule 144
   under the Securities Act ("Rule 144") may be made only in accordance with the
   terms of said Rule 144. The provisions of Section 4(a) and 4(b) hereof,
   together with the rights of the Purchaser under this Agreement and the other
   Primary Documents, shall be binding upon any subsequent transferee of the
   Common Stock.

(b) Restrictive Legend. The Purchaser acknowledges and agrees that, until such
   time as the Covered Warrants shall have been registered under the Securities
   Act or the Purchaser demonstrates to the reasonable satisfaction of the
   Company and its counsel that such registration shall no longer be required,
   such Covered Warrants may be subject to a stop-transfer order placed against
   the transfer of such Covered Warrants, and such Covered Warrants shall bear a
   restrictive legend in substantially the following form:

         THESE WARRANTS (INCLUDING ANY UNDERLYING CAPITAL STOCK) HAVE NOT BEEN
         REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT
         BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE
         TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO
         THE WARRANTS UNDER SAID ACT OR AN OPINION OF COUNSEL OR OTHER EVIDENCE
         REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION SHALL NO
         LONGER BE REQUIRED.

(c) Filings. The Company undertakes and agrees that it will make all required
   filings in connection with the sale of the Securities to the Purchaser as
   required by federal and state laws and regulations, or by any domestic
   securities exchange or trading market, and if applicable, the filing of a
   notice on Form D (at such time and in such manner as required by the rules
   and regulations of the Commission), and to provide copies thereof to the
   Purchaser promptly after such filing or filings. With a view to making
   available to the holders of the Securities the benefits of Rule 144 and any
   other rule or regulation of the Commission that may at any time permit such
   holder to sell securities of the Company to the public without registration
   or pursuant to a registration on Form S-3 or Form SB-2, the Company shall (a)
   at all times make and keep public information available, as those terms are
   understood and defined in Rule 144, (b) file on a timely basis with the
   Commission all information that the Commission may require under either of
   Section 13 or Section 15(d) of the Exchange Act and, so long as it is
   required to file such information, take all actions that may be required as a
   condition to the availability of Rule 144 (or any successor exemptive rule
   hereafter in effect) with respect to the Common Stock; and (d) furnish to any
   holder of the Securities forthwith upon request (i) a written statement by
   the Company as to its compliance with the reporting requirements of Rule 144,
   (ii) a copy of the most recent annual or quarterly report of the Company as
   filed with the Commission, and (iii) any other reports and documents that a
   holder of the Securities may reasonably request in order to avail itself of
   any rule or regulation of the Commission allowing such holder to sell any
   such Securities without registration.

                                       11

<PAGE>

(d) Reservation of Common Stock. The Company will at all times have authorized
   and reserved for the purpose of issuance a sufficient number of shares of
   Common Stock to provide for the conversion of the exercise of the Warrants.

(e) Return of Certificates on Conversion. Upon any exercise by any holder of the
   Warrants of less than all of the shares of Common Stock into which such
   Warrants are exercisable, the Company shall issue and deliver to the holder
   thereof, within seven business days of the date of exercise, a new Warrant
   exercisable for the total number of shares of Common Stock which the holder
   has not yet elected to exercise.

(f) Replacement Certificates. The Warrants will be exchangeable, at the option
   of the Purchaser, at any time and from time to time at the office of the
   Company, for other Warrants of different denominations entitling the holder
   thereof to purchase in the aggregate the same number of shares of Common
   Stock as are purchasable under such Warrants. No service charge will be made
   for such transfer or exchange.

(g) Financial Statements. At the expense of the Company, the Company's
   accountant shall annually prepare for each calendar year, a report of the
   Company, including a balance sheet, annual profit and loss statement, and
   annual cash flow statement to be furnished to the Purchaser within one
   hundred twenty (120) days after the end of each calendar year. In addition
   the Company shall cause to be prepared and distributed to the Purchaser for
   each calendar quarter during the term of this Agreement a report of the
   Company, including a balance sheet, quarterly profit and loss statement, and
   quarterly cash flow statement for such calendar quarter to be furnished to
   the Purchaser within forty-five (45) days after the end of each calendar
   quarter. The Company shall also cause to be prepared and filed all Federal,
   state and local income tax returns and information returns, if any, which the
   Company is required to file.

5. FEES AND EXPENSES

         The Company shall bear its own costs, including attorney's fees,
incurred in the negotiation of this Agreement and consummating of the
transactions contemplated herein and in the corporate proceedings of the Company
in contemplation hereof and thereof. At the date of execution and delivery
hereof, the Company shall reimburse the Purchaser for all of the Purchaser's
reasonable out-of-pocket expenses incurred in connection with the negotiation or
performance of this Agreement, including without limitation, reasonable fees and
disbursements of counsel to the Purchaser.

                                       12

<PAGE>

6.       SURVIVAL

         The agreements, covenants, representations and warranties of the
Company and the Purchaser shall survive the execution and delivery of this
Agreement and the delivery of the Warrants hereunder for a period of two years
from the date hereof, except that:
(a) the Company's representations and warranties regarding Taxes contained in
   Section 3(s) of this Agreement shall survive as long as the Company remains
   statutorily liable for any obligation referenced in Section 3(s), and

(b) the Company's representations and warranties contained in Section 3(b) shall
   survive until the Purchaser and any of its affiliates are no longer holders
   of any of the Warrants purchased hereunder.

7. INDEMNIFICATION

(a) The Company, on the one side, and the Purchaser (each in such capacity under
   this section, the "Indemnifying Party") agrees to indemnify the other party
   and each officer, director, employee, agent, partner, stockholder, member and
   affiliate of such other party (collectively, the "Indemnified Parties") for,
   and hold each Indemnified Party harmless from and against: (i) any and all
   damages, losses, claims, diminution in value and other liabilities of any and
   every kind, including, without limitation, judgments and costs of settlement,
   and (ii) any and all reasonable out-of-pocket costs and expenses of any and
   every kind, including, without limitation, reasonable fees and disbursements
   of counsel for such Indemnified Parties (all of which expenses periodically
   shall be reimbursed as incurred), in each case, arising out of or suffered or
   incurred in connection with any of the following, whether or not involving a
   third party claim: (a) any misrepresentation or any breach of any warranty
   made by the Indemnifying Party herein or in any of the other Primary
   Documents, (b) any breach or non-fulfillment of any covenant or agreement
   made by the Indemnifying Party herein or in any of the other Primary
   Documents, or (c) any claim relating to or arising out of a violation of
   applicable federal or state Warrants laws by the Indemnifying Party in
   connection with the sale or issuance of the Warrants by the Indemnifying
   Party to the Indemnified Party (collectively, the "Indemnified Liabilities").
   To the extent that the foregoing undertaking by the Indemnifying Party may be
   unenforceable for any reason, the Indemnifying Party shall make the maximum
   contribution to the payment and satisfaction of each of the Indemnified
   Liabilities which is permissible under applicable law.

8. NOTICES

         Any notice required or permitted hereunder shall be given in writing
(unless otherwise specified herein) and shall be effective upon personal
delivery, via facsimile (upon receipt of confirmation of error-free transmission
and mailing a copy of such confirmation, postage prepaid by certified mail,
return receipt requested) or three business days following deposit of such
notice with an internationally recognized courier service, with postage prepaid
and addressed to each of the other parties thereunto entitled at the following
addresses, or at such other addresses as a party may designate by five days
advance written notice to each of the other parties hereto.

                                       13

<PAGE>

         Company:                        Health Systems Solutions, Inc.
                                         405 North Reo Street, Suite 300
                                         Tampa, Florida 33609
                                         Attention:  B. M. Milvain, President
                                         Telephone:  813-282-3303
                                         Facsimile:    813-282-8907

         with a copy to:                 Stanford Financial Group
                                         5050 Westheimer
                                         Houston, TX 77056
                                         Attention: Mauricio Alvarado, Esq.
                                         Telephone: (713) 964-5145
                                         Facsimile: (713) 964-5245

         Purchaser:                      Stanford Venture Capital Holdings, Inc.
                                         6075 Poplar Avenue
                                         Memphis, TN 38119
                                         Attention: James M. Davis, President
                                         Telephone: (901) 680-5260
                                         Facsimile: (901) 680-5265

         with a copy to:                 Stanford Financial Group
                                         5050 Westheimer
                                         Houston, TX 77056
                                         Attention: Mauricio Alvarado, Esq.
                                         Telephone: (713) 964-5145
                                         Facsimile: (713) 964-5245

9. GOVERNING LAW; JURISDICTION

         This Agreement shall be governed by and interpreted in accordance with
the laws of the State of Florida, without regard to its principles of conflict
of laws. Any action or proceeding seeking to enforce any provision of, or based
on any right arising out of, this Agreement may be brought against any party in
the federal courts of Florida or the state courts of the State of Florida,
Miami-Dade County and each of the parties consents to the jurisdiction of such
courts and hereby waives, to the maximum extent permitted by law, any objection,
including any objections based on forum non conveniens, to the bringing of any
such proceeding in such jurisdictions.

                                       14

<PAGE>

10. MISCELLANEOUS

(a) Entire Agreement. This Agreement supersedes all prior agreements and
   understandings among the parties hereto with respect to the subject matter
   hereof. This Agreement, together with the other Primary Documents, including
   any certificate, schedule, exhibit or other document delivered pursuant to
   their terms, constitutes the entire agreement among the parties hereto with
   respect to the subject matters hereof and thereof, and supersedes all prior
   agreements and understandings, whether written or oral, among the parties
   with respect to such subject matters.

(b) Amendments. This Agreement may not be amended except by an instrument in
   writing signed by the party to be charged with enforcement.

(c) Waiver. No waiver of any provision of this Agreement shall be deemed a
   waiver of any other provisions or shall a waiver of the performance of a
   provision in one or more instances be deemed a waiver of future performance
   thereof.

(d) Construction. This Agreement and each of the Primary Documents have been
   entered into freely by each of the parties, following consultation with their
   respective counsel, and shall be interpreted fairly in accordance with its
   respective terms, without any construction in favor of or against either
   party.

(e) Binding Effect of Agreement. This Agreement shall inure to the benefit of,
   and be binding upon the successors and assigns of each of the parties hereto,
   including any transferees of the Warrants.

(f) Severability. If any provision of this Agreement shall be invalid or
   unenforceable in any jurisdiction, such invalidity or unenforceability shall
   not affect the validity or enforceability of the remainder of this Agreement
   or the validity or unenforceability of this Agreement in any other
   jurisdiction.

(g) Attorneys' Fees. If any action should arise between the parties hereto to
   enforce or interpret the provisions of this Agreement, the prevailing party
   in such action shall be reimbursed for all reasonable expenses incurred in
   connection with such action, including reasonable attorneys' fees.

(h) Headings. The headings of this Agreement are for convenience of reference
   only and shall not form part of, or affect the interpretation of this
   Agreement.

(i) Counterparts. This Agreement may be signed in one or more counterparts, each
   of which shall be deemed an original and all of which, when taken together,
   will be deemed to constitute one and the same agreement.

                         [SIGNATURES ON FOLLOWING PAGE]

                                       15

<PAGE>

         IN WITNESS WHEREOF, this Agreement has been duly executed by each of
the undersigned as of the date first written above.

                                         HEALTH SYSTEMS SOLUTIONS, INC.

                                         By:
                                            ------------------------------------
                                         Name:
                                               ---------------------------------
                                         Title:
                                                --------------------------------

                                         STANFORD VENTURE CAPITAL HOLDINGS, INC.

                                         By:
                                            ------------------------------------
                                         Name:
                                              ----------------------------------
                                         Title:
                                               ---------------------------------

                                       16

<PAGE>

                                  EXHIBIT INDEX

EXHIBIT A                                        WARRANT

EXHIBIT B                                        HSS CLOSING CERTIFICATE

EXHIBIT C                                        SVCH CLOSING CERTIFICATE

<PAGE>

                                    EXHIBIT B
                         HEALTH SYSTEMS SOLUTIONS, INC.
                              A Nevada Corporation

                               CLOSING CERTIFICATE

         The undersigned,  B.M. Milvain,  hereby certifies to Stanford Venture
Capital  Holdings,  Inc., a Delaware Corporation  ("SVCH"),  that he is the duly
elected and acting  President  of Health  Systems  Solutions,  Inc., a
Nevada corporation (the "Company"), and hereby further certifies to SVCH as
follows:

All capitalized terms used herein and not otherwise defined herein shall have
the meanings ascribed to such terms as in the Warrant Purchase Agreement dated
as of July 6, 2004 and entered into by and among the Company and SVCH (the
"Warrant Purchase Agreement"):

1.            Representations and Warranties. The representations and warranties
              made by the Company in the Warrant Purchase Agreement are true and
              correct in all respects on and as of the date hereof, as though
              made on and as of such date, except to the extent that any such
              representation or warranty expressly relates solely to an earlier
              date, in which case such representation or warranty is true and
              correct in all respects on and as of such earlier date.

2.            Covenants and Agreements. The Company has performed all covenants
              and agreements required to be performed pursuant to the Warrant
              Purchase Agreement in all respects on and as of the date hereof.

3.            Recent Events. Except as disclosed in the Warrant Purchase
              Agreement, there has not been any: (a) material adverse change or
              any material adverse development in the business, properties,
              operations, financial condition, prospects, outstanding securities
              or results or operations of the Company and no event has occurred
              or no circumstances exist that may result in such material adverse
              change; (b) no incurrence of any liability, fixed or contingent by
              the Company. The Company has not engaged in any practice, taken
              any action, or entered into any transaction, except as
              contemplated by the Warrant Purchase Agreement.

         IN WITNESS WHEREOF, the undersigned has executed this Officers'
Certificate this ___ day of July 2004.

___________________
B.M. Milvain
President

<PAGE>

                                    EXHIBIT C
                     STANFORD VENTURE CAPITAL HOLDINGS, INC.
                             A Delaware Corporation

                               CLOSING CERTIFICATE

         The undersigned, ______________, hereby certifies to Health Systems
Solutions, Inc., a Nevada corporation ("HSS"), that he is the duly elected and
acting President of Stanford Venture Capital Holdings, Inc., a Delaware
Corporation (the "Company"), and hereby further certifies to HSS as follows:

All capitalized terms used herein and not otherwise defined herein shall have
the meanings ascribed to such terms as in the Warrant Purchase Agreement dated
as of July 6, 2004 and entered into by and among the Company and HSS (the
"Warrant Purchase Agreement"):

1.            Representations and Warranties. The representations and warranties
              made by the Company in the Warrant Purchase Agreement are true and
              correct in all respects on and as of the date hereof, as though
              made on and as of such date, except to the extent that any such
              representation or warranty expressly relates solely to an earlier
              date, in which case such representation or warranty is true and
              correct in all respects on and as of such earlier date.

2.            Covenants and Agreements. The Company has performed all covenants
              and agreements required to be performed pursuant to the Warrant
              Purchase Agreement in all respects on and as of the date hereof.

         IN WITNESS WHEREOF, the undersigned has executed this Officers'
Certificate this ___ day of July 2004.

_________________
B.M. Milvain
PresidentWARRANT ASSIGNMENT

         THIS WARRANT ASSIGNMENT AGREEMENT, dated as of July 6, 2004 (the
"Agreement"), is entered into by and among Stanford Venture Capital Holdings,
Inc., a Delaware corporation ("Stanford"), Daniel T. Bogar ("Bogar"), Ronald M.
Stein ("Stein"), William M. Fusselmann ("Fusselmann") and Osvaldo Pi ("Pi" and
together with Bogar, Stein and Fusselmann each an "Assignee" and collectively
the "Assignees").

                              W I T N E S S E T H:

         WHEREAS, effective as of the date hereof, Health Systems Solutions,
Inc., a Nevada corporation ("HSS") entered into a certain Warrant Purchase
Agreement by and among HSS and Stanford (the "Securities Purchase Agreement");

         WHEREAS, pursuant to, and in accordance with, the Securities Purchase
Agreement, Stanford purchased and HSS sold and issued warrants to purchase up to
an aggregate of 720,000 shares of HSS common stock (the "HSS Warrants");

         WHEREAS, for value received, Stanford agreed to assign and transfer
unto each Assignee HSS Warrants exercisable for 90,000 HSS Warrant Shares (as
hereinafter defined) (the "HSS Assigned Warrants") with each share of common
stock represented by the HSS Warrants ("HSS Warrant Shares") exercisable at an
exercise price per HSS Warrant Share of $0.001;

         NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows:

A.       Stanford hereby assigns and transfers unto each Assignee, 90,000 HSS
         Warrant Shares exercisable at an exercise price per HSS Warrant Share
         of $0.001.

B.       The parties hereto hereby covenant and agree to take all such action as
         may be necessary or appropriate in order to carry out the actions set
         forth herein.

C.       This Agreement shall be governed by and interpreted in accordance with
         the laws of the State of Florida, without regard to its principles of
         conflict of laws.

D.       This Agreement supersedes all prior agreements and understandings among
         the parties hereto with respect to the subject matter hereof. This
         Agreement, constitutes the entire agreement among the parties hereto
         with respect to the subject matters hereof and thereof, and supersedes
         all prior agreements and understandings, whether written or oral, among
         the parties with respect to such subject matters.

E.       This Agreement shall inure to the benefit of, and be binding upon the
         successors and assigns of each of the parties hereto, including any
         transferees of the Warrants.

<PAGE>

F.       This Agreement may be signed in one or more counterparts, each of which
         shall be deemed an original and all of which, when taken together, will
         be deemed to constitute one and the same agreement.

                         *Signatures on Following Page*

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the date first written above.

Stanford Venture Capital Holdings, Inc.              "Assignees"

----------------------------                         ---------------------------
By:                                                  William R. Fusselmann
Title:                                               141 Crandon Blvd., #437
                                                     Key Biscayne, Florida 33149

                                                     ---------------------------
                                                     Daniel T. Bogar
                                                     1016 Sanibel Drive

                                                     ---------------------------
                                                     Ronald M. Stein
                                                     6520 Allison Road
                                                     Miami Beach, Florida 33141

                                                     ---------------------------
                                                     Osvaldo Pi
                                                     6405 SW 104th Street
                                                     Pinecrest, Florida 33156

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]